Literature DB >> 29442288

Updates of Peripheral T Cell Lymphomas Based on the 2017 WHO Classification.

Parwiz J Siaghani1, Joo Y Song2.   

Abstract

PURPOSE OF REVIEW: This review will describe and update the readers on the recent changes of the 2017 WHO classification in regard to peripheral T cell lymphomas. RECENT
FINDINGS: Significant advances in molecular studies have resulted in revisions of the classification as well as introduction of provisional entities (such as breast implant-associated ALCL, nodal PTCL with TFH phenotype). Major advances in molecular and gene expression profiling have expanded our knowledge of T cell lymphomas, including updates in the diagnostic criteria and sub-classification which will facilitate in improving patient care and research.

Entities:  

Keywords:  Classification; Molecular; Pathology; Peripheral T cell lymphoma

Mesh:

Year:  2018        PMID: 29442288     DOI: 10.1007/s11899-018-0429-y

Source DB:  PubMed          Journal:  Curr Hematol Malig Rep        ISSN: 1558-8211            Impact factor:   4.213


  98 in total

1.  Morphologic Features of ALK-negative Anaplastic Large Cell Lymphomas With DUSP22 Rearrangements.

Authors:  Rebecca L King; Linda N Dao; Ellen D McPhail; Elaine S Jaffe; Jonathan Said; Steven H Swerdlow; Christopher A Sattler; Rhett P Ketterling; Jagmohan S Sidhu; Eric D Hsi; Shridevi Karikehalli; Liuyan Jiang; Sarah E Gibson; Sarah L Ondrejka; Alina Nicolae; William R Macon; Surendra Dasari; Edgardo Parrilla Castellar; Andrew L Feldman
Journal:  Am J Surg Pathol       Date:  2016-01       Impact factor: 6.394

2.  Nodal peripheral T-cell lymphomas and, in particular, their lymphoepithelioid (Lennert's) variant are often derived from CD8(+) cytotoxic T-cells.

Authors:  Eva Geissinger; Tobias Odenwald; Seung-Sook Lee; Irina Bonzheim; Sabine Roth; Peter Reimer; Martin Wilhelm; Hans Konrad Müller-Hermelink; Thomas Rüdiger
Journal:  Virchows Arch       Date:  2004-07-29       Impact factor: 4.064

3.  Novel t(5;9)(q33;q22) fuses ITK to SYK in unspecified peripheral T-cell lymphoma.

Authors:  B Streubel; U Vinatzer; M Willheim; M Raderer; A Chott
Journal:  Leukemia       Date:  2006-02       Impact factor: 11.528

Review 4.  Refractory celiac disease: from bench to bedside.

Authors:  Georgia Malamut; Bertrand Meresse; Christophe Cellier; Nadine Cerf-Bensussan
Journal:  Semin Immunopathol       Date:  2012-07-19       Impact factor: 9.623

Review 5.  Association of celiac disease and intestinal lymphomas and other cancers.

Authors:  Carlo Catassi; Italo Bearzi; Geoffrey K T Holmes
Journal:  Gastroenterology       Date:  2005-04       Impact factor: 22.682

6.  Revising the historical collection of epithelioid cell-rich lymphomas of the Kiel Lymph Node Registry: what is Lennert's lymphoma nowadays?

Authors:  Sylvia Hartmann; Claudio Agostinelli; Wolfram Klapper; Penelope Korkolopoulou; Karoline Koch; Teresa Marafioti; Pier Paolo Piccaluga; Efstratios Patsouris; Stefano Pileri; Martin-Leo Hansmann
Journal:  Histopathology       Date:  2011-12       Impact factor: 5.087

7.  Angioimmunoblastic T-cell lymphoma with hyperplastic germinal centres: a neoplasia with origin in the outer zone of the germinal centre? Clinicopathological and immunohistochemical study of 10 cases with follicular T-cell markers.

Authors:  Manuel Rodriguez-Justo; Ayoma D Attygalle; Phillipa Munson; Giovanna Roncador; Teresa Marafioti; Miguel A Piris
Journal:  Mod Pathol       Date:  2009-03-27       Impact factor: 7.842

8.  Presentation and long-term follow-up of refractory celiac disease: comparison of type I with type II.

Authors:  Georgia Malamut; Pauline Afchain; Virginie Verkarre; Thierry Lecomte; Aurélien Amiot; Diane Damotte; Yoram Bouhnik; Jean-Frédéric Colombel; Jean-Charles Delchier; Matthieu Allez; Jacques Cosnes; Anne Lavergne-Slove; Bertrand Meresse; Ludovic Trinquart; Elizabeth Macintyre; Isabelle Radford-Weiss; Olivier Hermine; Nicole Brousse; Nadine Cerf-Bensussan; Christophe Cellier
Journal:  Gastroenterology       Date:  2008-10-07       Impact factor: 22.682

9.  Seroma-associated primary anaplastic large-cell lymphoma adjacent to breast implants: an indolent T-cell lymphoproliferative disorder.

Authors:  Anja C Roden; William R Macon; Gary L Keeney; Jeffrey L Myers; Andrew L Feldman; Ahmet Dogan
Journal:  Mod Pathol       Date:  2008-01-25       Impact factor: 7.842

10.  Mutations in the JAK/STAT and RAS signaling pathways are common in intestinal T-cell lymphomas.

Authors:  A Nicolae; L Xi; T H Pham; T-A Pham; W Navarro; H G Meeker; S Pittaluga; E S Jaffe; M Raffeld
Journal:  Leukemia       Date:  2016-06-22       Impact factor: 11.528

View more
  6 in total

1.  Clinicopathologic Features of Peripheral T-Cell Lymphoma in Sub-Saharan Africa.

Authors:  Megan J Fitzpatrick; Shahin Sayed; Zahir Moloo; Mukendi K A Kayembe; Drucilla J Roberts; Thu-Anh Pham; Liqiang Xi; Mark Raffeld; Abner Louissaint; Aliyah R Sohani
Journal:  Am J Clin Pathol       Date:  2021-06-17       Impact factor: 2.493

2.  High-Throughput Sequence Analysis of Peripheral T-Cell Lymphomas Indicates Subtype-Specific Viral Gene Expression Patterns and Immune Cell Microenvironments.

Authors:  Hani Nakhoul; Zhen Lin; Xia Wang; Claire Roberts; Yan Dong; Erik Flemington
Journal:  mSphere       Date:  2019-07-10       Impact factor: 4.389

3.  High activation of STAT5A drives peripheral T-cell lymphoma and leukemia.

Authors:  Barbara Maurer; Harini Nivarthi; Bettina Wingelhofer; Ha Thi Thanh Pham; Michaela Schlederer; Tobias Suske; Reinhard Grausenburger; Ana-Iris Schiefer; Michaela Prchal-Murphy; Doris Chen; Susanne Winkler; Olaf Merkel; Christoph Kornauth; Maximilian Hofbauer; Birgit Hochgatterer; Gregor Hoermann; Andrea Hoelbl-Kovacic; Jana Prochazkova; Cosimo Lobello; Abbarna A Cumaraswamy; Johanna Latzka; Melitta Kitzwögerer; Andreas Chott; Andrea Janikova; Šárka Pospíšilova; Joanna I Loizou; Stefan Kubicek; Peter Valent; Thomas Kolbe; Florian Grebien; Lukas Kenner; Patrick T Gunning; Robert Kralovics; Marco Herling; Mathias Müller; Thomas Rülicke; Veronika Sexl; Richard Moriggl
Journal:  Haematologica       Date:  2020-01-31       Impact factor: 9.941

4.  Clinical and pathological characteristics of peripheral T-cell lymphomas in a Spanish population: a retrospective study.

Authors:  Socorro Maria Rodriguez-Pinilla; Eva Domingo-Domenech; Fina Climent; Joaquin Sanchez; Carlos Perez Seoane; Javier Lopez Jimenez; Monica Garcia-Cosio; Dolores Caballero; Oscar Javier Blanco Muñez; Cecilia Carpio; Josep Castellvi; Antonio Martinez Pozo; Blanca Gonzalez Farre; Angeles Bendaña; Carlos Aliste; Ana Julia Gonzalez; Sonia Gonzalez de Villambrosia; Miguel A Piris; Jose Gomez Codina; Empar Mayordomo-Aranda; Belen Navarro; Carmen Bellas; Guillermo Rodriguez; Juan Jose Borrero; Ana Ruiz-Zorrilla; Marta Grande; Carmen Montoto; Raul Cordoba
Journal:  Br J Haematol       Date:  2020-05-19       Impact factor: 6.998

5.  Esophageal peripheral T-cell lymphoma treated with radiotherapy: A case report.

Authors:  Qiujing Zhang; Chengxiang Liu; Zining Liu; Menghan Liu; Chao Xie; Jinsong Zheng; Congcong Han; Dexian Zhang; Jianjun Zhang; Shuai Fu; Jie Liu
Journal:  Medicine (Baltimore)       Date:  2021-01-29       Impact factor: 1.817

6.  Real-Life Experience Regarding Clinical Characteristics and Treatment Outcome in Non-Cutaneous Peripheral T-Cell Lymphomas: A Multicenter Study of the Turkish Hematology Research and Education Group (ThREG)

Authors:  Ömür Kayıkçı; Özgür Mehtap; İsmail Sarı; Fatih Demirkan; Cengiz Beyan; Güven Çetin; Filiz Vural; Mehmet Yılmaz; Erman Öztürk; Seval Akpınar; Bülent Eser; Mehmet Gündüz; Yahya Büyükaşık; Bahriye Payzın; Rahşan Yıldırım; Mehmet Hilmi Doğu; Atilla Özkan; Engin Kelkitli; Emre Tekgündüz
Journal:  Turk J Haematol       Date:  2022-06-09       Impact factor: 2.029

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.